Yes. Beginning September 1, 2008, providers were encouraged to begin using National Drug Code (NDC) for physician-administered drugs, in conjunction with the customary Healthcare Common Procedure Coding System (HCPCS) Level I, II, or III code, on all Medi-Cal claims.
The Family PACT Program reimburses for treatment of Chlamydia only if the partner is enrolled in the Family PACT Program.
Family PACT providers must ensure that non-clinician counselors have been trained in all family planning methods; are knowledgeable about the Family PACT Standards and program benefits; and have the essential core competence to deliver education and counseling services, including individual client history and assessment of health education and counseling needs. Within the personnel files of non-clinician counselors, providers must maintain documentation of education and counseling training and performance. For more information about counseling by non-clinician counselors see the Office Visits Section of the Family PACT Policies, Procedures and Billing Instructions (PPBI).
Placement of the Essure® micro-inserts does not require general anesthesia and is designed to be performed in a physician’s office. However, as clinically indicated, it may be performed in an ambulatory surgery center or hospital outpatient surgery center.
Providers must maintain a written log or electronic record of all Essure® micro-inserts placed, including the client’s name, medical record and Family PACT client’s Health Access Program (HAP) card number, date of surgery, and lot number of the product, for at least five years from the date of insertion.
To ensure that health care providers receive instructions and training on insertion and removal, Merck has developed the Clinical Training Program for NEXPLANON®. Only those clinicians who have completed the training program are eligible to purchase the product. You can find information about the trainings on the following website:
In accordance with Family PACT policy, providers should keep a written log or electronic record of all Intrauterine Contraceptive (IUC) devices and contraceptive implants inserted for at least three years from the date of insertion. Records should include the following: (1) Client’s name; (2) medical record and Health Access Program (HAP) card number; (3) date of insertion; (4) type of IUC or implant; and (5) lot number of the device or product.
Rapid and conventional FDA-approved HIV diagnostic tests for HIV-1, HIV-2, and HIV-1&2 are covered for Family PACT clients. However, prevalence of HIV-2 in the U.S. is extremely low, and the CDC does not recommend routine HIV-2 testing in the U.S. Therefore, the clinician should order a test for HIV-1 only, unless the client is from West Africa (where HIV-2 is endemic) or has sex partners from endemic areas, has sex partners known to be infected with HIV-2, or has received a blood transfusion or non-sterile injection in a West African country.
Family PACT recommends that clinics make rapid testing available (in addition to conventional testing) if a significant percentage of clients are not likely to return for results or a high HIV prevalence is known to exist at the site.
No. Family PACT services are required to be provided at a clinic site.
No. Client eligibility determination and completion of the Client Eligibility Certification (CEC) Form must be completed at the time of the clinic visit.
OFP is responsible for the provision of comprehensive clinical family planning services as well as health education programs to low income women and men throughout California. Clinical family planning services are provided through the Family PACT Program. Community based educational services for all persons regarding pregnancy prevention are provided through the Information and Education Program (I&E).